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Summary
MicroRNAs (miRNAs) regulate gene expression with emerging
data suggesting miRNAs play a role in skeletal muscle biology.
We sought to examine the association of miRNAs with grip
strength in a community-based sample. Framingham Heart Study
Offspring and Generation 3 participants (n = 5668 54% women,
mean age 55 years, range 24, 90 years) underwent grip strength
measurement and miRNA profiling using whole blood from
fasting morning samples. Linear mixed-effects regression model-
ing of grip strength (kg) versus continuous miRNA ‘Cq’ values and
versus binary miRNA expression was performed. We conducted
an integrative miRNA–mRNA coexpression analysis and examined
the enrichment of biologic pathways for the top miRNAs
associated with grip strength. Grip strength was lower in women
than in men and declined with age with a mean 44.7 (10.0) kg in
men and 26.5 (6.3) kg in women. Among 299 miRNAs interro-
gated for association with grip strength, 93 (31%) had FDR
q value < 0.05, 54 (18%) had an FDR q value < 0.01, and 15 (5%)
had FDR q value < 0.001. For almost all miRNA–grip strength
associations, increasing miRNA concentration is associated with
increasing grip strength. miR-20a-5p (FDR q 1.8 3 106) had the
most significant association and several among the top 15
miRNAs had links to skeletal muscle including miR-126-3p, miR-
30a-5p, and miR-30d-5p. The top associated biologic pathways
included metabolism, chemokine signaling, and ubiquitin-
mediated proteolysis. Our comprehensive assessment in a com-
munity-based sample of miRNAs in blood associated with grip
strength provides a framework to further our understanding of
the biology of muscle strength.
Key words: aging; epidemiology; grip strength; microRNA;
mRNA.
Introduction
Hand grip strength is a simple and inexpensive measure of muscle
strength associated with exceptional survival (Willcox et al., 2006), all-
cause mortality, cardiovascular mortality, and cardiovascular disease
(Leong et al., 2015). Reduced grip strength is also associated with
impaired mobility (Sallinen et al., 2010) and risk for physical disability
(Cummings et al., 2014). Grip strength declines with age in both men
and women (Dodds et al., 2014) and is used as a criterion of frailty as
well as to define sarcopenia (low muscle mass and weakness; Studenski
et al., 2014), which are important causes of disability and death in the
community (Rodriguez-Manas & Fried, 2014). There is interest in this
measure as a phenotype of healthy aging and potentially to identify
older adults for interventions to promote healthy aging (Studenski et al.,
2014).
Biologic mechanisms influencing muscle strength maintenance and
decline are complex with many contributing factors (Gonzalez-Freire
et al., 2014). Physical inactivity, malnutrition, hormonal changes,
inflammatory pathway activation, mitochondrial dysfunction, obesity,
glycemia, and age-related diseases play a role in age-related loss of
muscle (Kalyani et al., 2014). In addition, genetic factors contribute
substantially to the variability in grip strength (Frederiksen et al., 2002),
suggesting that genetic studies may identify biologically relevant
pathways important to muscle strength and aging. However, few
genomewide association studies have been conducted of grip strength
(Chan et al., 2015; Matteini et al., 2016) with one identifying a
promising common variant in a chromosomal region linked to muscle
repair (Matteini et al., 2016).
MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene
expression by altering mRNA transcripts. Differential expression of
miRNAs has been associated with age (Noren et al., 2010, 2013) and
age-related diseases such as cancer and cardiovascular disease (Freed-
man et al., 2012). Emerging data suggest miRNAs may play a role in
skeletal muscle biology including skeletal muscle development, muscle
physiology, and specific muscle diseases (Goljanek-Whysall et al., 2012;
Kirby & McCarthy, 2013; Nie et al., 2015). Skeletal muscle-enriched
miRNAs have been identified in the circulation of both healthy individuals
and those with muscle disease (Alexander & Kunkel, 2015; Denham &
Prestes, 2016). In a small study of endurance athletes compared to
healthy controls, muscle-enriched circulating miRNAs with distinct roles
in muscle biology measured in whole blood predict cardiopulmonary
fitness parameters and change in abundance in response to a single bout
of maximum aerobic exercise (Denham & Prestes, 2016). However, much
of the work has been done in animal models and the molecular
mechanisms of most differentially expressed miRNAs in skeletal muscle
remain unknown. We had the opportunity to examine the association of
circulating miRNAs with hand grip strength in a community-based
sample of adults across a wide age range.
Results
Our investigation focused on Framingham Heart Study (FHS) Offspring
participants who attended examination cycle 8 (2005–2008, n = 3021)
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and Gen 3 participants who attended examination cycle 2 (2008–2011,
n = 3411), underwent hand grip strength testing, and had a blood
sample for miRNA expression profiling. The characteristics of the 5668
Offspring and Gen 3 participants (54% women, mean age 55 years,
range 24, 90 years) in the study sample are shown in Table 1 (Table S1,
Supporting information provides characteristics by cohort). Hand grip
strength was lower in women than in men and declined with age with a
mean 44.7 (10.0) kg in men and 26.5 (6.3) kg in women (Fig. 1).
Linear mixed-effects regression modeling of grip strength (kg) versus
continuous miRNA ‘Cq’ values and also versus binary miRNA expression
for miRNAs with measurable expression in at least 5% of the sample was
conducted (see Experimental procedures for details). Among 299
miRNAs interrogated for association with hand grip strength, 112
(37%) had FDR q value < 0.10, 93 (31%) had FDR q value < 0.05, 54
(18%) had an FDR q value < 0.01, and 15 (5%) had FDR q
value < 0.001 in models adjusted for sex, age, height, BMI, and
technical variables (Table 2, Table S2, Supporting information). With
further adjustment for cell counts (Table S3, Supporting information), we
observed largely similar results. Among the top 15 associations in the
primary analysis (Table 2), two-thirds of miRNAs remained among
the top 15 associations after adjusting for cell counts. The majority of the
associations shown in Table 2 are derived from the continuous model
(miRNA Cq values) with the exceptions of miR-26a-1-3p where the
association is observed in the binary model (miRNA expression yes/no)
and miR-668, miR-25-5p, and miR-1304-5p where the association is
observed in both models. For almost all miRNA–hand grip associations,
increasing miRNA concentration is associated with increasing grip
strength. The direction of effect is consistent for the two models
(continuous Cq values, binary expression yes/no) for most miRNAs. We
examined the miRNAs expressed in > 90% of samples separately in men
and women. There were 70 miRNAs in women and 48 miRNAs in men
associated with hand grip at P < 0.05 (Table S4, Supporting informa-
tion). Among the top 15 miRNA associations, a greater number were
seen among the top results in men than in women and the magnitude of
most estimates was larger in men; however, the direction of the effect
estimates were similar in men and women (Table S4, Supporting
information).
Of 67 miRNAs reported to be associated with skeletal muscle
development, muscle fiber physiology, or muscle disease in the published
literature, nine were assayed and three were expressed in the FHS
sample (Table S5, Supporting information). miR-206 was associated with
hand grip (FDR q = 0 = 0.012). Additionally, miR-503 was expressed in
56 participants and associated with hand grip strength (FDR q = 0.002),
however given the small sample results need to be interpreted with
caution.
To better understand how the top 15 miRNAs associated with hand
grip strength might contribute to muscle strength and healthy aging, we
analyzed miRNA–mRNA coexpression in the same set of FHS participants
(n = 5340) in whom miRNA and mRNA expression data were both
available (Table S6, Supporting information). At an FDR < 0.05, there
were 2895 miRNA–mRNA coexpressed pairs that ranged from 0 to 1 pair
for a given miRNA (miR-18a-5p-a1, miR-1304-5p, respectively) to 477
pairs (miR-126-3p). These pairs consisted of 1560 unique mRNA genes,
which were considered as potential genes targets of 15 hand grip
strength-associated miRNAs. Among the 2895 pairs, 1394 pairs were
also predicted by TargetScan. We also examined the 2895 miRNA–
mRNA pairs for the presence of the 150 genes derived from muscle that
denote a healthy aging gene signature (Sood et al., 2015). There were
31 miRNA–mRNA pairs among this healthy aging signature representing
17 unique genes. Next, we examined the 1560 unique genes from the
coexpressed miRNA–mRNA pairs in WebGestalt to identify enrichment
of biologic pathways. The top ten biologic pathways are consistent with
pathways important not only with muscle function but with aging itself
including metabolic, chemokine signaling, ubiquitin-mediated proteoly-
sis, and RNA transport among others (Table 3). Table S7 (Supporting
information) lists the genes and associated miRNAs in each pathway. We
also tested the enrichment of these potential gene targets among
known aging-related pathways, and found that both the insulin
signaling pathway and mTOR pathway (gene list in Table S8, Supporting
information) were significantly enriched (P = 3.58E-6 and P = 6.52e-5,
respectively). Interestingly, the potential gene targets were also highly
enriched (P < 1e-16) with aging-related genes identified previously
(Peters et al., 2015). Finally, we conducted a miRNA–mRNA coexpres-
sion analysis for 11 miRNAs with a positive beta estimate (negative
association with grip strength) among the 93 miRNA–grip associations
with FDR < 0.05 in our primary analysis (Table S2, Supporting
Table 1 Characteristics of the study sample
Characteristic
Overall
(N = 5668)
Men
(N = 2616)
Women
(N = 3052)
Age, years 55.7 (13.2) 55.7 (13.1) 55.7 (13.2)
Women % 54 – –
Grip Strength, kg 34.9 (12.3) 44.7 (10.0) 26.5 (6.3)
Height, inches 66.4 (3.75) 69.3 (2.67) 63.9 (2.5)
BMI, kg m2 28.1 (5.6) 29.0 (4.9) 27.3 (6.1)
Current smoking, % 10 11 10
Hypertension, % 41 46 37
Diabetes, % 8.8 11.3 6.7
Total cholesterol, mg dL1 186 (36) 181 (36) 191 (35)
HDL cholesterol. mg dL1 59 (18) 50 (14) 66 (18)
Triglyceride, mg dL1 115 (76) 127 (92) 105 (57)
Physical activity index 36 (6.1) 37 (7.3) 35 (4.9)
Cardiovascular disease, % 8.2 10.8 6.0
Data are presented as mean (SD) or percentage.
Figure 1 Hand grip strength (kg) by age groups in men and women. Plot
shows mean and standard error bars for 5-year age groups by sex. Men (mean
44.6 kg, SD 10.2); women (mean 26.2 kg, SD 6.5). A fitted regression with a
quadratic age term in hashed lines estimates the rate of decline in grip strength.
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information) and conducted pathway analysis on the 920 unique
associated genes. The top biologic pathways with FDR < 0.05 relate to
immune function, chemokine signaling, and apoptosis among others
(Table S9, Supporting information, pathways, genes, and associated
miRNAs for each pathway). Many of the 11 miRNAs come from the
present/absent model and are not significant in the model with
continuous Cq expression values (model restricted to participants with
detectable levels of the miRNA) and four of the 11 miRNAs are available
in a sample of under 1000 individuals.
Discussion
In the present study, we examined the relation of 299 miRNAs measured
in whole blood and hand grip strength in a community-based sample of
men and women across a wide age range. In our sample, 93 miRNAs
were associated with hand grip strength (FDR q < 0.05). For the top 15
miRNAs, increasing miRNA concentration was associated with increasing
grip strength for nearly all associations. Using an integrative miRNA–
mRNA coexpression analysis, we identified the potential gene targets
(N = 1560 unique genes) for the top 15 hand grip strength-associated
miRNAs. Consistent with our hypothesis that grip strength is a healthy
aging phenotype, the top biologic pathways were important to aging
itself and the potential gene targets were enriched for previously
identified age-related genes.(Peters et al., 2015).
miR-20a-5p, the strongest miRNA associated with hand grip strength
in our study, is a member of the miR-17 family known to have many
biologic functions including a role in hepatic insulin resistance (Fang
et al., 2016). Its function in muscle is not well studied nor completely
understood; however, recent work suggests a potential role as a
biomarker for osteosarcoma (Li et al., 2015). Several miRNAs among the
top 15 hand grip strength-associated miRNAs have links to skeletal
muscle. A small study of healthy young and old men demonstrated that
miR-126 was downregulated after resistance exercise in older men but
not young men (Rivas et al., 2014). Follow-up mechanistic work revealed
that decreased miR-126 in proliferating myoblasts impacts the IGF-1
signaling pathway, an important regulator of skeletal muscle growth.
This noted impairment in exercise-induced miRNA regulation with aging
and the associated inhibition of the IGF-1 signaling may provide a
mechanism for age-related muscle loss such as sarcopenia (Rivas et al.,
2014). The miR-30-5p family is known to play a role in cardiomyocyte
and vascular smooth muscle cell pathophysiology (Balderman et al.,
2012; Yin et al., 2013). In animal models, the miR-30 family (including
miR-30a-5p and miR-30d-5p) regulates differentiation of myoblasts and
may be a biomarker of disturbed muscle homeostasis (Guess et al.,
2015). Recent work in bovine models supports a role for miR-30-5p in
skeletal muscle development and regulation of alternative splicing of key
muscle genes by targeting the MBNL (muscleblind-like) family (Zhang
et al., 2016).
Table 3 Top biologic pathways based on miRNA–mRNA coexpression pairs from
top 15 miRNAs and the unique 1500 associated genes
Pathway name
Genes in
pathway
Ratio of
enrichment P-value FDR Q value
Metabolic pathways 102 2.60 2.0E-18 3.5E-16
Chemokine signaling
pathway
36 5.49 7.5E-17 6.5E-15
Regulation of actin
cytoskeleton
37 5.01 6.4E-16 2.8E-14
Endocytosis 36 5.16 5.8E-16 2.8E-14
Ubiquitin-mediated
proteolysis
28 5.98 2.1E-14 7.3E-13
Huntington’s disease 32 5.04 4.8E-14 1.4E-12
Alzheimer’s disease 30 5.18 1.4E-13 3.5E-12
RNA transport 27 5.15 2.6E-12 5.6E-11
Protein processing in
endoplasmic reticulum
27 4.72 2.2E-11 4.3E-10
Spliceosome 23 5.22 8.1E-11 1.4E-09
Table 2 Top 15 miRNA associations with hand grip strength: Framingham Heart Study
miRNA N
Linear regression, continuous miRNA:
Cq values
Linear regression, binary miRNA expression
(yes/no)
FDR q†Est Beta SE P-value Est Beta SE P-value
miR-20a-5p 5467 0.20 0.03 6.03E-09 0.38 0.49 0.44 1.80E-06
miR-183-3p 5492 0.23 0.04 1.94E-08 0.65 0.53 0.22 2.90E-06
miR-29b-2-5p 5280 0.32 0.06 5.78E-08 0.86 0.37 1.94E-02 4.60E-06
miR-601 5542 0.18 0.03 6.15E-08 1.54 0.63 1.46E-02 4.60E-06
miR-766-3p 5557 0.29 0.05 8.23E-08 0.27 0.66 0.69 4.92E-06
miR-320b 5608 0.33 0.06 1.73E-07 0.64 0.89 0.47 7.43E-06
miR-942 5597 0.30 0.06 1.74E-07 1.41 0.82 8.32E-02 7.43E-06
miR-26a-1-3p 4820 0.10 0.06 7.23E-02 1.33 0.27 8.69E-07 3.85E-05
miR-30d-5p 5604 0.24 0.05 1.16E-06 0.49 0.86 0.57 3.85E-05
miR-30a-5p 5634 0.25 0.05 3.62E-06 0.54 1.17 0.64 1.08E-04
miR-126-3p 5621 0.17 0.04 8.31E-06 0.84 0.995 0.40 2.25E-04
miR-668 4985 0.12 0.04 1.91E-03 1.05 0.29 2.30E-04 2.25E-04
miR-25-5p 5389 0.22 0.05 1.25E-05 1.42 0.43 9.18E-04 2.88E-04
miR-18a-5p-a1 5432 0.15 0.04 3.09E-05 0.95 0.46 3.96E-02 6.60E-04
miR-1304-5p 1469 0.14 0.04 3.46E-04 0.57 0.21 7.29E-03 8.75E-04
Models adjusted for age, sex, height, body mass index, technical covariates (RNA concentration, 260/280, RNA quality).
†Based on adaptive P-values see statistical methods. Higher Cq values indicate lower miRNA expression levels. Therefore, negative beta values indicate positive associations
between miRNA expression and grip strength.
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miRNA analysis conducted on skeletal muscle biopsies from young
and older adults identified the Let-7 family, significantly Let-7b and Let-
7e, as having higher expression in older adults (Drummond et al., 2011).
All mean let-7 levels for the 10 family members assayed in that study
were higher in older subjects raising the possibility that the Let-7 family
members work together to alter gene expression or that with further
aging additional Let-7 family members would become significant (the
sample size was small). In our study, several Let-7 family members
assayed in blood were associated with hand grip strength (Let-7c FDR
q = 0.005, Let-7g-5p FDR q = 0.004, Let-7e-5 FDR q = 0.013, Let-7a-5p
FDR q = 0.03). The Let-7 family is important in tumor suppression and
cell cycle control. It is possible that increased expression of Let-7 with
aging impairs cellular proliferation and muscle regeneration capacity
(Drummond et al., 2011).
We looked up the miRNAs reported to be associated with skeletal
muscle development, muscle fiber physiology, or muscle disease in the
published literature in our study results and found that miR-206 was
significantly associated with hand grip strength (FDR q = 0.012). miR-
206 is a muscle-enriched miRNA known as myomiRs and has been
associated with a number of age-associated changes in muscle patho-
physiology including changes in type II muscle fibers, reduction in
neuromuscular junction signaling, and decreases in muscle satellite cell
numbers (Brown & Goljanek-Whysall, 2015; Nie et al., 2015). In studies
of young and old mice, expression of miR-206 has been associated with
age-related muscle atrophy which may provide insights into the human
age-related condition of sarcopenia (Kim et al., 2014; Nie et al., 2015).
Participants in our sample had both miRNA and mRNA data
permitting a coexpression analysis of the top 15 miRNAs associated
with grip strength and a further examination of the potential unique
gene targets of the miRNAs. The genes were enriched for age-related
genes (Peters et al., 2015) and biologic pathways important in muscle
physiology including among the top ten pathways metabolism,
chemokine signaling, RNA transport, and ubiquitin-mediated proteolysis
(Lopez-Otin et al., 2013). The ubiquitin/proteasome pathway (UPP) plays
a crucial role in muscle health including muscle cell differentiation,
muscle growth and integrity, and muscle mass maintenance (Bell et al.,
2016). There were many ubiquitin genes (Table S6, Supporting
information) in our pathway analysis associated with the top 15 hand
grip-associated miRNAs. It is of interest that the genes associated with
the downregulated miRNAs from the miRNA–mRNA coexpression
function in biologic pathways linked to immune function and inflam-
mation given the key role this pathway plays in muscle strength decline
(Gonzalez-Freire et al., 2014) and aging.
Our study had several strengths including the number of miRNAs
profiled, the large sample size and broad age range of participants, and
the community-based setting unselected for any specific disease. The
study also has limitations including the lack of race/ethnic diversity
limiting generalizability of findings beyond participants of white,
European ancestry background. The miRNAs were assayed in blood as
our study is an epidemiologic cohort study without accessibility to
muscle tissue; however, several of our findings are consistent with small
studies (n < 50) of miRNAs profiled in skeletal muscle biopsies. Finally,
our findings need to be replicated in an independent sample and further
functional studies to determine the underlying biologic mechanisms of
the miRNA–grip strength associations are needed.
In conclusion, in our community-based sample of men and women
across a wide age range, we identified 93 miRNAs associated with hand
grip strength. The potential gene targets for the top associations are
linked to biologic pathways important to muscle and aging including
metabolism, chemokine signaling, and ubiquitin-mediated proteolysis.
These results need to be replicated in an independent human sample but
provide a framework to further our understanding of the biology of
muscle strength and healthy aging phenotypes.
Experimental procedures
Study sample
The Framingham Heart Study (FHS) is an ongoing prospective commu-
nity-based family study that includes the Offspring cohort enrolled in
1971 and the children of the Offspring participants who were enrolled in
the Third Generation cohort (Gen 3) in 2002 (Splansky et al., 2007). For
the present investigation, we focused on Offspring participants who
attended examination cycle 8 (2005–2008, n = 3021) and Gen 3
participants who attended examination cycle 2 (2008–2011, n = 3411),
underwent hand grip strength testing, and had a blood sample for
miRNA expression profiling. We excluded 108 participants with missing
grip strength data, 638 participants without miRNA expression data, and
18 participants with missing covariate data providing a study sample of
5668 participants. All participants provided informed consent and the
examination protocols were approved by the Boston University Medical
Center Institutional Review Board.
Hand grip measurement
Hand grip strength was obtained by trained technicians with a JAMAR
dynamometer (Model #5030J1, Sammons Preston/JLW Instruments,
Chicago, IL, USA) using the same protocol for both Offspring and Gen 3
participants. The participant was seated with forearm resting on the arm
of a chair and instructed to hold the dynamometer upright and squeeze
as hard as able. Three trials in the right hand and then the left hand were
recorded. The maximum of the six trials was used for analysis.
miRNA expression profiling
Whole blood from fasting morning samples were used for miRNA
profiling. The high-throughput Gene Expression Core Laboratory at the
University of Massachusetts Medical School profiled all TaqMan miRNA
commercially available assays (n = 774) available at the start of the
Systems Approach to Biomarker Research in Cardiovascular Disease
(SABRe CVD) Project (McManus et al., 2017). If the miRNA was not
detected in a sample of 550 participants, it was removed from further
study and not measured in the full cohort. The remaining miRNA
profiling in FHS was carried out on 346 miRNAs using quantitative real-
time polymerase chain reaction (RT-qPCR) using TaqMan chemistry-
based miRNA assays. The qPCRs were conducted using a high-
throughput instrument (BioMark, Fluidigm, San Francisco, CA, USA). In
reproducibility analysis, for replicates > 95% of data points had
coefficients of variation < 10%. miRNA expression is quantified using
cycle threshold (Cq) where lower Cq values represent higher miRNA
expression levels. Low expression using the nano-volume Fluidigm
system is considered as a Cq value of 27 or higher. We evaluated 299
miRNAs with measurable Cq values in at least 5% (250) of participants.
Gene expression (mRNA)
Gene expression profiling was performed from blood samples taken on
Offspring examination 8 (n = 2442) and Gen 3 examination 2
(n = 3180) as previously described (Joehanes et al., 2013). In brief, the
Affymetrix Human Exon 1.0 ST Array (Affymetrix, Inc, Santa Clara, CA)
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was used and gene annotations were obtained from Affymetrix NetAffx
Analysis Center (version 31) resulting in 17,324 distinct genes for
downstream analysis.
Covariates
At each FHS examination, height and weight were obtained according to
standardized protocols and body mass index was calculated as weight in
kilograms divided by the square of the height in meters (kg m2). Resting
blood pressure was obtained twice by the physician and hypertensionwas
considered present if the average blood pressure measurement was
≥ 140/90 or the participant reported antihypertensive medications.
Fasting laboratory measurements include glucose and lipids. Diabetes
was defined as a fasting plasmaglucose> 125 mg dL1 or treatmentwith
medications. Current smokers were defined as smoking 1 or more
cigarettes per day during the year prior to the examination. Participants
reported the number of hours per day spent in sleep, sedentary, slight,
moderate, and heavy activities to calculate the physical activity index.
Prevalent cardiovascular disease was defined as coronary heart disease,
stroke, or intermittent claudication using previously established criteria.
Statistical analysis
Many participants did not express some miRNAs at detectable levels.
Therefore, for each miRNA in each participant, we defined a binary
variable to code whether the miRNA was not detectable: X = 1 if
Cq > 27, 0 otherwise. Thus, X = 1 corresponds with low (undetectable)
concentration, whereas X = 0 corresponds with detectable miRNA
concentration. We fitted two linear mixed-effects regression models for
eachmiRNA: (model 1) in everyone, grip ~ X and covariates, and (model 2)
in the subset having X = 0, grip ~Cq and covariates. We combined results
from these two analyses as follows. If an miRNA was expressed in < 10%
of samples, we used only model 1; if it was expressed in at least 90% of
samples, we used only model 2; if it was expressed in 10% to < 90% of
samples, we added chi-squared statistics from bothmodels and calculated
a P-value from a chi-squared distribution with two degrees of freedom.
Our primary analysis adjusted for sex, age, height, BMI, and technical
variables (RNA concentration, RNA quality, and RNA 260/280 ratio). For
miRNAs expressed in at least 90% of samples, we examined associations
with grip strength separately in women and men to assess whether the
relations were similar in both sexes.
In secondary analyses, we also adjusted for cell counts: red blood cell
count, white blood cell count, platelets, percent neutrophil, percent
lymphocytes, percent monocytes, and percent eosinophils. [Blood cell
counts were measured in Gen 3 participants and partial least-squares
regression was used to impute cell counts with 10-fold cross-validation
(Pilling et al., 2015)]. Imputed cell counts were used in these analyses.
To evaluate our approach, we conducted permutation testing by
separating miRNA data from clinical data (hand grip and covariates: age,
sex, BMI, RNA quality, concentration, 260/280 ratio, and cell count
variables). We randomly ordered the clinical data, merged that with
miRNA data, and fitted the two covariate-adjusted models for grip versus
(i) binary and ((ii) continuous miRNA. From each pair of models, we
calculated P-values using the adaptive test. We ran 100 replicates to
examine distributions of adaptive P-values and we established that type I
error was not inflated.
Following regression analyses, we examined miRNAs reported in the
literature to be associated with skeletal muscle development, muscle fiber
physiology, or muscle disease such as sarcopenia in humans or animal
models (Goljanek-Whysall et al., 2012; Smith-Vikos& Slack, 2012; Kirby &
McCarthy, 2013; McGregor et al., 2014; Rivas et al., 2014; Nie et al.,
2015) to determinewhether thesemiRNAswere assayed and expressed in
our community sample of adults. Finally, we checked whether those
expressed miRNAs were associated with hand grip strength.
miRNA–mRNA coexpression and pathway analysis
We also performed a miRNA–mRNA coexpression analysis among
Offspring and Gen 3 participants with both miRNA and mRNA data.
Linear mixed-effects models (R package lmekin() function) were used to
conduct pairwise coexpression analyses for all profiled mRNAs
(N = 17,318) and the top 15 miRNAs. Significant miRNA–mRNA coex-
pression pairs were selected using FDR < 0.05. TargetScan v7.0 (Lewis
et al., 2005; Agarwal et al., 2015) was used to predict whether the
mRNAs were the corresponding targets for the miRNAs for the
coexpressed miRNA–mRNA pairs identified. Pathway analyses were
conducted in DAVID Bioinformatics resources 6.7 (https://david.ncifc
rf.gov/) (Huang et al., 2009), and WebGestalt (Wang et al., 2013) to
identify significant biologic mechanisms associated with the unique genes
that were associated with the top 15 miRNAs. In addition, we examined
the enrichment of grip strength-related genes in key aging pathways
(insulin signaling/IGF1/FOXO and mTOR pathways) and among the genes
associatedwith aging in a large humanmeta-analysis (Peters et al., 2015).
The key aging pathways have also been important in muscle physiology
with insulin-like growth factors important to muscle cell differentiation
and muscle regeneration (Zanou & Gailly, 2013). Finally, we investigated
whether the 150 genes comprising the RNA signature of healthy human
aging derived from muscle tissue (Sood et al., 2015) were targets of the
top 15 miRNAs associated with hand grip in this study.
We conducted a second miRNA–mRNA coexpression analysis for
miRNAs that were negatively associated with grip strength. Among 93
miRNA–hand grip associations with FDR < 0.05 in our primary analysis
(Table S2, Supporting information), we identified 11 miRNAs with a
positive beta estimate (miR-149-5p, miR-126-5p, miR-1249, miR-193b-
3p, miR-219-1-3p, miR-1274A, miR-1276, miR-1179, miR-99b-3p, miR-
491-5p, miR-543). Four of the 11 miRNAs come from the present/absent
model and are not significant in the model with continuous Cq expression
values. Of note, four of the 11 miRNAs are available in a sample of under
1000 individuals. We ran miRNA–mRNA coexpression and conducted
pathway analyses using the same methods described above.
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